Rational Design of a Bifunctional AND-Gate Ligand To Modulate Cell-Cell Interactions.
Jungmin LeeAndyna VernetKatherine RedfieldShulin LuIonita C GhiranJeffrey C WayPamela A SilverPublished in: ACS synthetic biology (2019)
Protein "AND-gate" systems, in which a ligand acts only on cells with two different receptors, direct signaling activity to a particular cell type and avoid action on other cells. In a bifunctional AND-gate protein, the molecular geometry of the protein domains is crucial. Here we constructed a tissue-targeted erythropoietin (EPO) that stimulates red blood cell (RBC) production without triggering thrombosis. The EPO was directed to RBC precursors and mature RBCs by fusion to an anti-glycophorin A antibody V region. Many such constructs activated EPO receptors in vitro and stimulated RBC and not platelet production in mice but nonetheless enhanced thrombosis in mice and caused adhesion between RBCs and EPO-receptor-bearing cells. On the basis of a protein-structural model of the RBC surface, we rationally designed an anti-glycophorin-EPO fusion that does not induce cell adhesion in vitro or enhance thrombosis in vivo. Thus, mesoscale geometry can inform the design of synthetic-biological systems.
Keyphrases
- red blood cell
- induced apoptosis
- cell cycle arrest
- pulmonary embolism
- protein protein
- single cell
- cell adhesion
- binding protein
- amino acid
- endoplasmic reticulum stress
- oxidative stress
- cell therapy
- high fat diet induced
- metabolic syndrome
- signaling pathway
- stem cells
- staphylococcus aureus
- pseudomonas aeruginosa
- escherichia coli
- cystic fibrosis
- highly efficient
- adipose tissue
- insulin resistance
- pi k akt